29/05/2019
Pharmaceutical enterprises take the initiative to reduce prices: "4 + 7" pilot effect "beyond expectations"
多地药企主动降价,“4+7”试点效果“超出预期”!
On January 1 2019, the General Office of the State Council issued the Pilot Program for the Centralized Procurement and Use of Drugs by the State Organization. On April 1, 11 pilot cities were fully launched.
"Beyond expectations!" Chen Jinfu, deputy director of the State Medical Security Bureau, commented on the implementation of centralized drug procurement.
In the "4 + 7" pilot area, 25 drug varieties were selected, with the average price reduction of 52% and the maximum reduction of 96%. Through the strength of the state, the urgent needs of the common people have been solved through the exchange of market volume and price.
Centralized recruitment, one-time evaluation, price-limited procurement, imported generic drugs into domistic market... With changes of whole environment, what challenges will China's pharmaceutical industry encounter?
今年1月1日,国务院办公厅印发《国家组织药品集中采购和使用试点方案》。4月1日,11个试点城市全面启动实施。
“超出预期!”国家医疗保障局副局长陈金甫这样评价药品集中采购的实施情况。“4+7”试点地区中,25个药品品种中选,中选价平均降幅达52%,最高降幅达到96%。通过国家的力量,以市场换量、换价,确实解决了老百姓燃眉之急。
集中招采、一次性评价、限价采购、进口仿制药进入……面对市场环境的变化,中国的制药行业又将面临何种转变?
https://www.linkedin.com/company/13738581/